HEADER TRANSPORT PROTEIN 02-JUN-23 8JLE TITLE CRYO-EM STRUCTURE OF SV2A LD4 IN COMPLEX WITH BONT/A2 HC IN THE SV2A- TITLE 2 LEVETIRACETAM-BONT/A2 HC COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: SYNAPTIC VESICLE GLYCOPROTEIN 2A; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: BOTULINUM NEUROTOXIN; COMPND 7 CHAIN: B; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SV2A; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: CLOSTRIDIUM BOTULINUM; SOURCE 10 ORGANISM_TAXID: 1491; SOURCE 11 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 12 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS SYNAPTIC VESICLE, EPILEPSY, TRANSPORT PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR A.YAMAGATA REVDAT 3 16-OCT-24 8JLE 1 REMARK REVDAT 2 08-MAY-24 8JLE 1 JRNL REVDAT 1 01-MAY-24 8JLE 0 JRNL AUTH A.YAMAGATA,K.ITO,T.SUZUKI,N.DOHMAE,T.TERADA,M.SHIROUZU JRNL TITL STRUCTURAL BASIS FOR ANTIEPILEPTIC DRUGS AND BOTULINUM JRNL TITL 2 NEUROTOXIN RECOGNITION OF SV2A. JRNL REF NAT COMMUN V. 15 3027 2024 JRNL REFN ESSN 2041-1723 JRNL PMID 38637505 JRNL DOI 10.1038/S41467-024-47322-4 REMARK 2 REMARK 2 RESOLUTION. 2.82 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : CRYOSPARC, CRYOSPARC, COOT, REFMAC, REMARK 3 CRYOSPARC, CRYOSPARC, CRYOSPARC, REMARK 3 CRYOSPARC REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 2.820 REMARK 3 NUMBER OF PARTICLES : 646723 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 8JLE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 09-JUN-23. REMARK 100 THE DEPOSITION ID IS D_1300038170. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : SV2A IN COMPLEX WITH BONT/A2 HC REMARK 245 DOMAIN AND ANTI-EPILEPTIC DRUG, REMARK 245 LEVETIRACETAM REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.50 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : 6518 REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 BIOQUANTUM (6K X REMARK 245 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 800.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2000.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : 2.70 REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5080.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS B 871 REMARK 465 ASN B 872 REMARK 465 ILE B 873 REMARK 465 VAL B 874 REMARK 465 ASN B 875 REMARK 465 LEU B 1296 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 ND2 ASN A 548 O5 NAG A 602 1.97 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 547 NE - CZ - NH2 ANGL. DEV. = -3.5 DEGREES REMARK 500 ARG B1140 NE - CZ - NH1 ANGL. DEV. = 3.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 497 77.92 -161.26 REMARK 500 LYS B 884 -159.27 -148.74 REMARK 500 LYS B 885 92.79 -69.09 REMARK 500 ARG B 893 47.65 -84.33 REMARK 500 PRO B 950 178.07 -59.15 REMARK 500 TYR B 980 109.71 -49.31 REMARK 500 TYR B1071 83.40 52.62 REMARK 500 THR B1145 36.97 -143.81 REMARK 500 THR B1146 100.38 32.10 REMARK 500 ASN B1147 -0.42 83.19 REMARK 500 ASP B1227 -168.87 -78.48 REMARK 500 ASP B1256 58.69 36.45 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-36394 RELATED DB: EMDB REMARK 900 CRYO-EM STRUCTURE OF SV2A LD4 IN COMPLEX WITH BONT/A2 HC IN THE REMARK 900 SV2A-LEVETIRACETAM-BONT/A2 HC COMPLEX DBREF 8JLE A 480 587 UNP Q7L0J3 SV2A_HUMAN 480 587 DBREF 8JLE B 871 1296 UNP D2KCK3 D2KCK3_CLOBO 871 1296 SEQRES 1 A 108 TYR ALA SER ARG THR LYS VAL PHE PRO GLY GLU ARG VAL SEQRES 2 A 108 GLU HIS VAL THR PHE ASN PHE THR LEU GLU ASN GLN ILE SEQRES 3 A 108 HIS ARG GLY GLY GLN TYR PHE ASN ASP LYS PHE ILE GLY SEQRES 4 A 108 LEU ARG LEU LYS SER VAL SER PHE GLU ASP SER LEU PHE SEQRES 5 A 108 GLU GLU CYS TYR PHE GLU ASP VAL THR SER SER ASN THR SEQRES 6 A 108 PHE PHE ARG ASN CYS THR PHE ILE ASN THR VAL PHE TYR SEQRES 7 A 108 ASN THR ASP LEU PHE GLU TYR LYS PHE VAL ASN SER ARG SEQRES 8 A 108 LEU ILE ASN SER THR PHE LEU HIS ASN LYS GLU GLY CYS SEQRES 9 A 108 PRO LEU ASP VAL SEQRES 1 B 426 LYS ASN ILE VAL ASN THR SER ILE LEU SER ILE VAL TYR SEQRES 2 B 426 LYS LYS ASP ASP LEU ILE ASP LEU SER ARG TYR GLY ALA SEQRES 3 B 426 LYS ILE ASN ILE GLY ASP ARG VAL TYR TYR ASP SER ILE SEQRES 4 B 426 ASP LYS ASN GLN ILE LYS LEU ILE ASN LEU GLU SER SER SEQRES 5 B 426 THR ILE GLU VAL ILE LEU LYS ASN ALA ILE VAL TYR ASN SEQRES 6 B 426 SER MET TYR GLU ASN PHE SER THR SER PHE TRP ILE LYS SEQRES 7 B 426 ILE PRO LYS TYR PHE SER LYS ILE ASN LEU ASN ASN GLU SEQRES 8 B 426 TYR THR ILE ILE ASN CYS ILE GLU ASN ASN SER GLY TRP SEQRES 9 B 426 LYS VAL SER LEU ASN TYR GLY GLU ILE ILE TRP THR LEU SEQRES 10 B 426 GLN ASP ASN LYS GLN ASN ILE GLN ARG VAL VAL PHE LYS SEQRES 11 B 426 TYR SER GLN MET VAL ASN ILE SER ASP TYR ILE ASN ARG SEQRES 12 B 426 TRP ILE PHE VAL THR ILE THR ASN ASN ARG LEU THR LYS SEQRES 13 B 426 SER LYS ILE TYR ILE ASN GLY ARG LEU ILE ASP GLN LYS SEQRES 14 B 426 PRO ILE SER ASN LEU GLY ASN ILE HIS ALA SER ASN LYS SEQRES 15 B 426 ILE MET PHE LYS LEU ASP GLY CYS ARG ASP PRO ARG ARG SEQRES 16 B 426 TYR ILE MET ILE LYS TYR PHE ASN LEU PHE ASP LYS GLU SEQRES 17 B 426 LEU ASN GLU LYS GLU ILE LYS ASP LEU TYR ASP SER GLN SEQRES 18 B 426 SER ASN SER GLY ILE LEU LYS ASP PHE TRP GLY ASN TYR SEQRES 19 B 426 LEU GLN TYR ASP LYS PRO TYR TYR MET LEU ASN LEU PHE SEQRES 20 B 426 ASP PRO ASN LYS TYR VAL ASP VAL ASN ASN ILE GLY ILE SEQRES 21 B 426 ARG GLY TYR MET TYR LEU LYS GLY PRO ARG GLY SER VAL SEQRES 22 B 426 VAL THR THR ASN ILE TYR LEU ASN SER THR LEU TYR GLU SEQRES 23 B 426 GLY THR LYS PHE ILE ILE LYS LYS TYR ALA SER GLY ASN SEQRES 24 B 426 GLU ASP ASN ILE VAL ARG ASN ASN ASP ARG VAL TYR ILE SEQRES 25 B 426 ASN VAL VAL VAL LYS ASN LYS GLU TYR ARG LEU ALA THR SEQRES 26 B 426 ASN ALA SER GLN ALA GLY VAL GLU LYS ILE LEU SER ALA SEQRES 27 B 426 LEU GLU ILE PRO ASP VAL GLY ASN LEU SER GLN VAL VAL SEQRES 28 B 426 VAL MET LYS SER LYS ASP ASP GLN GLY ILE ARG ASN LYS SEQRES 29 B 426 CYS LYS MET ASN LEU GLN ASP ASN ASN GLY ASN ASP ILE SEQRES 30 B 426 GLY PHE ILE GLY PHE HIS LEU TYR ASP ASN ILE ALA LYS SEQRES 31 B 426 LEU VAL ALA SER ASN TRP TYR ASN ARG GLN VAL GLY LYS SEQRES 32 B 426 ALA SER ARG THR PHE GLY CYS SER TRP GLU PHE ILE PRO SEQRES 33 B 426 VAL ASP ASP GLY TRP GLY GLU SER SER LEU HET NAG E 1 14 HET NAG E 2 14 HET FUC E 3 10 HET NAG A 601 14 HET NAG A 602 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN FUC ALPHA-L-FUCOSE; 6-DEOXY-ALPHA-L-GALACTOPYRANOSE; L- HETSYN 2 FUC FUCOSE; FUCOSE FORMUL 3 NAG 4(C8 H15 N O6) FORMUL 3 FUC C6 H12 O5 HELIX 1 AA1 PHE A 562 TYR A 564 5 3 HELIX 2 AA2 LYS B 929 VAL B 933 5 5 HELIX 3 AA3 SER B 954 LEU B 958 5 5 HELIX 4 AA4 ASN B 1080 SER B 1092 1 13 HELIX 5 AA5 GLU B 1210 GLY B 1215 5 6 HELIX 6 AA6 ASN B 1265 LYS B 1273 1 9 SHEET 1 AA1 6 LYS A 485 VAL A 492 0 SHEET 2 AA1 6 THR A 500 PHE A 512 1 O ARG A 507 N GLY A 489 SHEET 3 AA1 6 LYS A 515 GLU A 527 1 O GLU A 527 N HIS A 506 SHEET 4 AA1 6 LEU A 530 GLU A 532 0 SHEET 5 AA1 6 THR A 550 ILE A 552 1 O THR A 550 N PHE A 531 SHEET 6 AA1 6 ARG A 570 ILE A 572 1 O ILE A 572 N PHE A 551 SHEET 1 AA2 9 PHE A 566 VAL A 567 0 SHEET 2 AA2 9 PHE A 545 ARG A 547 1 N PHE A 546 O VAL A 567 SHEET 3 AA2 9 LYS A 515 GLU A 527 1 N PHE A 526 O PHE A 545 SHEET 4 AA2 9 THR A 500 PHE A 512 1 N HIS A 506 O GLU A 527 SHEET 5 AA2 9 TYR A 535 SER A 542 0 SHEET 6 AA2 9 VAL A 555 THR A 559 1 O VAL A 555 N PHE A 536 SHEET 7 AA2 9 SER A 574 LEU A 577 1 O THR A 575 N PHE A 556 SHEET 8 AA2 9 SER B1142 VAL B1144 -1 O VAL B1144 N SER A 574 SHEET 9 AA2 9 LEU B1150 SER B1152 -1 O ASN B1151 N VAL B1143 SHEET 1 AA3 5 ASP B 887 ASP B 890 0 SHEET 2 AA3 5 SER B 877 LYS B 884 -1 N VAL B 882 O ILE B 889 SHEET 3 AA3 5 ILE B1067 PHE B1075 -1 O LEU B1074 N ILE B 878 SHEET 4 AA3 5 GLN B 913 LEU B 916 -1 N ILE B 914 O ILE B1069 SHEET 5 AA3 5 TYR B 905 TYR B 906 -1 N TYR B 905 O LYS B 915 SHEET 1 AA4 7 ASP B 887 ASP B 890 0 SHEET 2 AA4 7 SER B 877 LYS B 884 -1 N VAL B 882 O ILE B 889 SHEET 3 AA4 7 ILE B1067 PHE B1075 -1 O LEU B1074 N ILE B 878 SHEET 4 AA4 7 PHE B 941 LYS B 948 -1 N TRP B 946 O LYS B1070 SHEET 5 AA4 7 ILE B1015 ASN B1021 -1 O ILE B1015 N ILE B 947 SHEET 6 AA4 7 SER B1027 ILE B1031 -1 O LYS B1028 N THR B1020 SHEET 7 AA4 7 ARG B1034 LYS B1039 -1 O ASP B1037 N ILE B1029 SHEET 1 AA5 3 LYS B 897 ILE B 900 0 SHEET 2 AA5 3 ILE B 924 ILE B 927 -1 O ILE B 927 N LYS B 897 SHEET 3 AA5 3 LYS B1052 PHE B1055 -1 O ILE B1053 N VAL B 926 SHEET 1 AA6 4 TYR B 962 ASN B 966 0 SHEET 2 AA6 4 GLY B 973 ASN B 979 -1 O LEU B 978 N TYR B 962 SHEET 3 AA6 4 GLU B 982 GLN B 988 -1 O ILE B 984 N SER B 977 SHEET 4 AA6 4 ILE B 994 LYS B1000 -1 O VAL B 997 N TRP B 985 SHEET 1 AA7 2 TYR B1112 ASN B1115 0 SHEET 2 AA7 2 TRP B1282 ILE B1285 -1 O ILE B1285 N TYR B1112 SHEET 1 AA8 2 TYR B1122 VAL B1125 0 SHEET 2 AA8 2 MET B1134 LYS B1137 -1 O LYS B1137 N TYR B1122 SHEET 1 AA9 7 LYS B1159 LYS B1164 0 SHEET 2 AA9 7 ARG B1179 VAL B1186 -1 O TYR B1181 N LYS B1163 SHEET 3 AA9 7 VAL B1220 LYS B1226 -1 O VAL B1221 N VAL B1180 SHEET 4 AA9 7 ARG B1232 GLN B1240 -1 O GLN B1240 N VAL B1220 SHEET 5 AA9 7 ASP B1246 TYR B1255 -1 O GLY B1248 N LEU B1239 SHEET 6 AA9 7 ILE B1258 SER B1264 -1 O ILE B1258 N TYR B1255 SHEET 7 AA9 7 LYS B1204 ILE B1205 -1 N LYS B1204 O ALA B1263 SHEET 1 AB1 4 LYS B1159 LYS B1164 0 SHEET 2 AB1 4 ARG B1179 VAL B1186 -1 O TYR B1181 N LYS B1163 SHEET 3 AB1 4 LYS B1189 ALA B1194 -1 O LYS B1189 N VAL B1186 SHEET 4 AB1 4 SER B1207 LEU B1209 -1 O SER B1207 N ALA B1194 LINK ND2 ASN A 498 C1 NAG A 601 1555 1555 1.68 LINK ND2 ASN A 548 C1 NAG A 602 1555 1555 1.66 LINK ND2 ASN A 573 C1 NAG E 1 1555 1555 1.49 LINK O4 NAG E 1 C1 NAG E 2 1555 1555 1.44 LINK O6 NAG E 1 C1 FUC E 3 1555 1555 1.42 CISPEP 1 GLY B 1138 PRO B 1139 0 -7.06 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000